机构:[1]Department of Rheumatology and Clinical Immunology, Chinese Academy of Medical Sciences and Peking Union Medical College, National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), Ministry of Science and Technology, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital (PUMCH), Key Laboratory of Rheumatology and Clinical Immunology, Ministry of Education, Beijing, China.[2]CAS Key Laboratory of Mental Health, Institute of Psychology, Beijing, China.[3]University of Chinese Academy of Sciences, Beijing, China.[4]Department of Epidemiology and Biostatistics, School of Basic Medicine Peking Union Medical College, Institute of Basic Medical Sciences Chinese Academy of Medical Sciences, Beijing, China.[5]Department of International Education, The Experimental High School Attached to Beijing Normal University, Beijing, China.[6]Department of Rheumatology, The People's Hospital of Xinjiang Autonomous, Urumqi, China.[7]Department of Rheumatology, First Affiliated Hospital of Guangxi Medical University, Nanning, China.[8]Department of Clinical Immunology and Rheumatology, Xijing Hospital Affiliated with The Fourth Military Medical University, Xi'an, China.[9]Department of Rheumatology, The Second Affiliated Hospital of Nanchang University, Nanchang, China.[10]Department of Rheumatology, First Affiliated Hospital of Kunming Medical University, Kunming, China.昆明医科大学附属第一医院[11]Department of Rheumatology, Hainan Provincial People's Hospital, Haikou, China.[12]Department of Rheumatology, Nanfang Hospital, Southern Medical University, Guangzhou, China.[13]Department of Rheumatology, First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.[14]Department of Rheumatology, The First People's Hospital of Yunnan Province, Kunming, China.云南省第一人民医院
the Chinese National
Key Technology R&D Program, Ministry of Science and
Technology (2021YFC2501301-5 and 2017YFC0907601-3),
Beijing Municipal Science and Technology Commission (No.
Z201100005520022, 23, and 25–27), and CAMS Innovation
Fund for Medical Sciences (CIFMS) (2021-I2M-1-005).
第一作者机构:[1]Department of Rheumatology and Clinical Immunology, Chinese Academy of Medical Sciences and Peking Union Medical College, National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), Ministry of Science and Technology, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital (PUMCH), Key Laboratory of Rheumatology and Clinical Immunology, Ministry of Education, Beijing, China.
共同第一作者:
通讯作者:
通讯机构:[2]CAS Key Laboratory of Mental Health, Institute of Psychology, Beijing, China.[3]University of Chinese Academy of Sciences, Beijing, China.
推荐引用方式(GB/T 7714):
Shi Yue,Bi Dandan,Wang Yanhong,et al.Chinese SLE Treatment and Research Group Registry (CSTAR) XIV: the subjective well-being of patients with systemic lupus erythematosus[J].FRONTIERS IN MEDICINE.2022,9:doi:10.3389/fmed.2022.984183.
APA:
Shi Yue,Bi Dandan,Wang Yanhong,Li Ruofan,Wu Lijun...&Zeng Xiaofeng.(2022).Chinese SLE Treatment and Research Group Registry (CSTAR) XIV: the subjective well-being of patients with systemic lupus erythematosus.FRONTIERS IN MEDICINE,9,
MLA:
Shi Yue,et al."Chinese SLE Treatment and Research Group Registry (CSTAR) XIV: the subjective well-being of patients with systemic lupus erythematosus".FRONTIERS IN MEDICINE 9.(2022)